BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Jan. 26, 2005
View Archived Issues
OctoPlus Raises EUR18.25M For Drug Development, Delivery
OctoPlus BV raised €18.25 million (US$23.6 million) in a second funding round that will enable it to progress its drug development and delivery programs and to widen its product pipeline. (BioWorld International)
Read More
CeNeS Gets Positive Phase III Data For M6G, Plans Another
Read More
Immune Cells Reprogrammed As Cancer Killers, Study Shows
Read More
Stroke Company Paion AG Testing German IPO Waters
Read More
Crucell Mulls Funding Moves For Clinical Studies In 2005
Read More
UroGene Sells Research Center, Cancer Programs to Pierre Fabre
Read More
With More Phase III Data, GW Hoping For IND Filing In U.S.
Read More
Other News To Note
Read More